Metformin and Its Therapeutic Applications in Autoimmune Inflammatory Rheumatic Disease

Overview

Journal Korean J Intern Med

Specialty General Medicine

Date 2021 Dec 8

PMID 34879473

Citations 16

Authors

Ji-Won Kim

Jung-Yoon Choe

Sung-Hwan Park

Affiliations

Soon will be listed here.

Abstract

Metformin is a first-line therapeutic agent for type 2 diabetes. Apart from its glucose-lowering effect, metformin is attracting interest regarding possible therapeutic benefits in various other conditions. As metformin regulates cell metabolism, proliferation, growth, and autophagy, it may also modulate immune cell functions. Given that metformin acts on multiple intracellular signaling pathways, including adenosine monophosphate (AMP)-activated protein kinase (AMPK) activation, and that AMPK and its downstream intracellular signaling control the activation and differentiation of T and B cells and inflammatory responses, metformin may exert immunomodulatory and anti- inflammatory effects. The efficacy of metformin has been investigated in preclinical and clinical studies on rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, Sjögren's syndrome, scleroderma, ankylosing spondylitis, and gout. In this review, we discuss the potential mechanisms through which metformin exerts its therapeutic effects in these diseases, focusing particularly on rheumatoid arthritis and osteoarthritis.

Citing Articles

Recent advances in the management of knee osteoarthritis: a narrative review.

Shtroblia V, Petakh P, Kamyshna I, Halabitska I, Kamyshnyi O Front Med (Lausanne). 2025; 12:1523027.

PMID: 39906596 PMC: 11790583. DOI: 10.3389/fmed.2025.1523027.

Disclosing the impact of metformin and methotrexate in adjuvant arthritis in female rats: molecular docking and biochemical insights on visfatin.

Mahmoud A, Alfadl E, Ahmed A, Abouelella A, Alshazly O, Mohamed M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39878818 DOI: 10.1007/s00210-025-03823-7.

Exploring microRNA pathways and metformin's anti-inflammatory potential in osteoarthritis.

La Q, Tangkamolsuk B, Lo D ACR Open Rheumatol. 2025; 7(1):e11771.

PMID: 39800669 PMC: 11725400. DOI: 10.1002/acr2.11771.

Metformin in Antiviral Therapy: Evidence and Perspectives.

Halabitska I, Petakh P, Lushchak O, Kamyshna I, Oksenych V, Kamyshnyi O Viruses. 2025; 16(12.

PMID: 39772244 PMC: 11680154. DOI: 10.3390/v16121938.

Immunomodulatory Effects of SGLT2 Inhibitors and Metformin in Managing Rheumatic Diseases: A Narrative Review.

Nallathambi N, Bisaralli R, Mamadapur M Mediterr J Rheumatol. 2024; 35(3):411-421.

PMID: 39463877 PMC: 11500115. DOI: 10.31138/mjr.010324.ies.

References

Dawood A, Alzamil N, Ebrahim H, Abdel Kader D, Kamar S, Haidara M . Metformin pretreatment suppresses alterations to the articular cartilage ultrastructure and knee joint tissue damage secondary to type 2 diabetes mellitus in rats. Ultrastruct Pathol. 2020; 44(3):273-282. DOI: 10.1080/01913123.2020.1762815. View

Lee S, Moon S, Kim E, Seo H, Yang E, Son H . Metformin Suppresses Systemic Autoimmunity in Mice through Inhibiting B Cell Differentiation into Plasma Cells via Regulation of AMPK/mTOR/STAT3. J Immunol. 2017; 198(7):2661-2670. PMC: 5357783. DOI: 10.4049/jimmunol.1403088. View

Indo Y, Takeshita S, Ishii K, Hoshii T, Aburatani H, Hirao A . Metabolic regulation of osteoclast differentiation and function. J Bone Miner Res. 2013; 28(11):2392-9. DOI: 10.1002/jbmr.1976. View

Thomas C, Fuller C, Whittles C, Sharif M . Chondrocyte death by apoptosis is associated with cartilage matrix degradation. Osteoarthritis Cartilage. 2006; 15(1):27-34. DOI: 10.1016/j.joca.2006.06.012. View

Bartok B, Firestein G . Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010; 233(1):233-55. PMC: 2913689. DOI: 10.1111/j.0105-2896.2009.00859.x. View

El-Sayyad S, Ali M, Kandil L, M Ragab G, Abdelhamid Ibrahim S . Metformin and omega-3 fish oil elicit anti-inflammatory effects via modulation of some dysregulated micro RNAs expression and signaling pathways in experimental induced arthritis. Int Immunopharmacol. 2021; 92:107362. DOI: 10.1016/j.intimp.2020.107362. View

Schadler P, Lohberger B, Stundl N, Stradner M, Glanzer D, Sadoghi P . The Effect of Body Mass Index and Metformin on Matrix Gene Expression in Arthritic Primary Human Chondrocytes. Cartilage. 2020; 13(2_suppl):1004S-1018S. PMC: 8804722. DOI: 10.1177/1947603520962558. View

Karatas A, Celik C, Oz B, Akar Z, Etem E, Dagli A . Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis. Int J Rheum Dis. 2021; 24(6):795-802. DOI: 10.1111/1756-185X.14114. View

Foretz M, Hebrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G . Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010; 120(7):2355-69. PMC: 2898585. DOI: 10.1172/JCI40671. View

10.

Jhun J, Lee S, Kim S, Na H, Kim E, Kim J . Combination therapy with metformin and coenzyme Q10 in murine experimental autoimmune arthritis. Immunopharmacol Immunotoxicol. 2015; 38(2):103-12. DOI: 10.3109/08923973.2015.1122619. View

11.

Moran E, Mullan R, McCormick J, Connolly M, Sullivan O, FitzGerald O . Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies. Arthritis Res Ther. 2009; 11(4):R113. PMC: 2745795. DOI: 10.1186/ar2772. View

12.

You S, Koh J, Leng L, Kim W, Bucala R . The Tumor-Like Phenotype of Rheumatoid Synovium: Molecular Profiling and Prospects for Precision Medicine. Arthritis Rheumatol. 2017; 70(5):637-652. PMC: 5920713. DOI: 10.1002/art.40406. View

13.

Matsuoka Y, Morimoto S, Fujishiro M, Hayakawa K, Kataoka Y, Suzuki S . Metformin repositioning in rheumatoid arthritis. Clin Exp Rheumatol. 2020; 39(4):763-768. View

14.

Li H, Ding X, Terkeltaub R, Lin H, Zhang Y, Zhou B . Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior. Arthritis Res Ther. 2020; 22(1):34. PMC: 7036179. DOI: 10.1186/s13075-020-2129-y. View

15.

Wang H, Li T, Chen S, Gu Y, Ye S . Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin. Arthritis Rheumatol. 2015; 67(12):3190-200. DOI: 10.1002/art.39296. View

16.

Vasamsetti S, Karnewar S, Kanugula A, Thatipalli A, Kumar J, Kotamraju S . Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis. Diabetes. 2015; 64(6):2028-41. DOI: 10.2337/db14-1225. View

17.

Bartok B, Boyle D, Liu Y, Ren P, Ball S, Bugbee W . PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritis. Am J Pathol. 2012; 180(5):1906-16. DOI: 10.1016/j.ajpath.2012.01.030. View

18.

Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y . Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006; 203(12):2673-82. PMC: 2118166. DOI: 10.1084/jem.20061775. View

19.

Yin Y, Choi S, Xu Z, Zeumer L, Kanda N, Croker B . Glucose Oxidation Is Critical for CD4+ T Cell Activation in a Mouse Model of Systemic Lupus Erythematosus. J Immunol. 2015; 196(1):80-90. PMC: 4684991. DOI: 10.4049/jimmunol.1501537. View

20.

Wang C, Yao Z, Zhang Y, Yang Y, Liu J, Shi Y . Metformin Mitigates Cartilage Degradation by Activating AMPK/SIRT1-Mediated Autophagy in a Mouse Osteoarthritis Model. Front Pharmacol. 2020; 11:1114. PMC: 7393141. DOI: 10.3389/fphar.2020.01114. View